Thena Capital, an all-female general partner firm based in London, has successfully closed its debut fund at £45 million. The fund will focus on supporting early-stage startups operating in the digital healthcare and medical devices sectors across the United Kingdom.
The new fund represents a significant entry into the healthcare investment landscape for the London-based team. Thena Capital’s focus extends beyond domestic support, with the firm planning to help portfolio companies expand into the United States market, positioning the fund as a bridge between UK innovation and broader North American opportunities.
Supporting UK Health Innovation
Digital healthcare and medical devices represent one of Europe’s most dynamic sectors, with startups developing solutions ranging from diagnostic tools to patient management platforms. Thena Capital’s debut fund addresses a recognized gap in venture capital support for these companies during their critical growth phases. The £45 million raised will enable the firm to back multiple companies through seed and early-stage funding rounds, providing both capital and strategic guidance.
The focus on medical devices and digital health solutions reflects broader industry trends in Europe, where regulatory frameworks and healthcare systems create both challenges and opportunities for innovative companies. Startups in this space often require patient capital and deep sector expertise to navigate complex regulatory pathways while building viable business models.
Transatlantic Expansion Strategy
Thena Capital’s inclusion of US market expansion support in its investment thesis signals confidence in the quality of UK-based health innovators and recognition of the significant opportunities available in the American healthcare market. This approach provides portfolio companies with more than capital—it offers operational guidance and connections to help them establish themselves internationally.
The strategy aligns with broader patterns in European venture capital, where successful funds increasingly provide support extending beyond initial funding to help startups scale across multiple geographies. For UK-based startups particularly, access to US market expertise and connections can be instrumental in achieving the growth trajectories required to compete globally.
European Context
The establishment of Thena Capital’s debut fund contributes to the growing diversity of investor profiles in European healthcare technology. The UK remains one of Europe’s strongest hubs for health innovation, with London serving as a major center for digital health investment and development. The launch of new, specialized funds focused on this sector underscores continued investor confidence in European healthcare startups’ potential to develop solutions with international impact.
As European startups increasingly compete for capital and market share against well-funded competitors in the United States and Asia, the emergence of funds combining deep sector expertise with international expansion support addresses a genuine market need. Thena Capital’s debut represents one of several recent moves by European investors to strengthen their positions in the competitive healthcare technology landscape.